Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Antimetabolite Cancer Therapy, Rational Drug DesignBispecific T-cell Engager Pioneer

George Hitchings

PhD

🏢Burroughs Wellcome Co. (historical)🌐USA

Pharmacologist, Nobel Laureate (1905-1998) — Antimetabolite Pioneer

0
0
Key Papers
0
Key Contributions

👥Biography 个人简介

George Hitchings was a Nobel Prize-winning pharmacologist who, together with Gertrude Elion, pioneered rational drug design by exploiting differences between nucleic acid metabolism in cancer cells and normal cells. His work led to 6-mercaptopurine, which became the first effective treatment for childhood leukemia, and the antiviral and immunosuppressive drug azathioprine. The rational drug design principles he established are the intellectual ancestry of all modern targeted cancer therapy. He and Elion shared the 1988 Nobel Prize in Physiology or Medicine for their discoveries.

Share:

🧪Research Fields 研究领域

antimetabolite drug design rational pharmacology
6-mercaptopurine leukemia treatment
azathioprine immunosuppression
Nobel Prize Medicine 1988 rational pharmacology
purine analogue cancer therapy history

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 George Hitchings 的研究动态

Follow George Hitchings's research updates

留下邮箱,当我们发布与 George Hitchings(Burroughs Wellcome Co. (historical))相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment